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Outer surface lipoprotein C (OspC) is a key virulence factor of Borrelia burgdorferi. ospC is differentially
regulated during borrelial transmission from ticks to rodents, and such regulation is essential for maintaining
the spirochete in its natural enzootic cycle. Recently, we showed that the expression of ospC in B. burgdorferi
is governed by a novel alternative sigma factor regulatory network, the RpoN-RpoS pathway. However, the
precise mechanism by which the RpoN-RpoS pathway controls ospC expression has been unclear. In particular,
there has been uncertainty regarding whether ospC is controlled directly by RpoS (s) or indirectly through a
transactivator (induced by RpoS). Using deletion analyses and genetic complementation in an OspC-deficient
mutant of B. burgdorferi, we analyzed the cis element(s) required for the expression of ospC in its native
borrelial background. Two highly conserved upstream inverted repeat elements, previously implicated in ospC
regulation, were not required for ospC expression in B. burgdorferi. Using similar approaches, a minimal
promoter that contained a canonical ⴚ35/ⴚ10 sequence necessary and sufficient for s-dependent regulation
of ospC was identified. Further, targeted mutagenesis of a C at position ⴚ15 within the extended ⴚ10 region
of ospC, which is postulated to function like the strategic C residue important for Es binding in Escherichia
coli, abolished ospC expression. The minimal ospC promoter also was responsive to coumermycin A1, further
supporting its s character. The combined data constitute a body of evidence that the RpoN-RpoS regulatory
network controls ospC expression by direct binding of s to a s-dependent promoter of ospC. The implication
of our findings to understanding how B. burgdorferi differentially regulates ospC and other ospC-like genes via
the RpoN-RpoS regulatory pathway is discussed.
Borrelia burgdorferi, the spirochetal agent of Lyme disease, is
maintained in nature via a complex enzootic cycle involving
Ixodes scapularis ticks and small rodents (50, 51). During transmission, the spirochete differentially expresses many of its constituent proteins for adaptation to its diverse host environments. Among those differentially regulated in this manner are
outer surface lipoproteins A (OspA) and C (OspC) (11, 31, 32,
47, 48). OspA is expressed principally by spirochetes harbored
in unfed, flat ticks and functions as an essential adhesion molecule for colonization and survival within the tick midgut (34–
36, 62). OspC, which is upregulated in B. burgdorferi at the time
of tick engorgement, is essential for the B. burgdorferi infection
of mice (21) and for the migration of B. burgdorferi from tick
midguts to salivary glands (15, 20, 37).
Given their importance in the life cycle of B. burgdorferi
and/or the pathogenesis of Lyme disease, the elucidation of the
regulatory networks that govern the differential expression of
OspA and OspC has become a central focus for understanding
the molecular mechanisms by which B. burgdorferi adapts to its
disparate host environments. However, the discernment of the
molecular basis of gene regulation in B. burgdorferi generally
has been hampered by a lack of systems for genetically manip-

ulating the spirochete, particularly for virulent strains (7, 56).
Nonetheless, recent advances in borrelial genetics have led to
the development of selectable markers and shuttle vectors (5,
12, 14, 16, 44, 45, 53), targeted gene inactivations (for a review,
see reference 41), and identification of B. burgdorferi virulence
factors (21, 37, 39, 62). Similar advances also have culminated
in the discovery of the first B. burgdorferi genetic regulatory
network, the RpoN-RpoS pathway (25, 61). In this pathway, a
two-component response regulator, Rrp2, functions as an enhancer-binding protein (EBP), along with the alternative sigma
factor RpoN (N), to control the expression of another alternative sigma factor, RpoS (s). RpoS, in turn, regulates the
expression of OspC, other “group I” lipoproteins (e.g., DbpA
and the Mlp family) (58, 59), and additional infection-associated immunogens (61).
The discovery of the RpoN-RpoS regulatory network
prompts an important question concerning how s, in particular, induces the expression of ospC and other virulence-associated genes. One possibility is that s controls ospC expression
via an unidentified transactivator, which could bind to the
regulatory region for the activation of ospC. Relative to this
hypothesis, two sets of conserved inverted repeats (IRs) located upstream of the ospC promoter (Fig. 1) have been proposed to be candidate binding sites for a potential transactivator(s) (29, 55). An alternative possibility is that ospC
contains a s-dependent promoter; in this case, s would directly control the transcriptional activation of ospC by binding
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FIG. 1. Upstream regions of the ospC genes of B. burgdorferi strains 297 and B31. Pairs of divergent arrows denote the two putative inverted
repeat elements (IR1 and IR2). The ⫺35 and ⫺10 promoter elements, ribosomal-binding site (RBS), and the ATG start codon are shown in
boldface type. Filled arrowheads indicate the starting positions of each deletion (⌬) described in the legend to Fig. 3A. The ⫺15 C residue (boxed)
within the extended ⫺10 region was targeted for mutagenesis. The asterisks mark two previously identified transcriptional initiation sites (28, 29,
33). min, start of deletion made to yield the minimal promoter construct diagrammed in Fig. 3A.

to the ospC promoter. Along these lines, predicated on determinations of transcriptional initiation, ospC has been predicted
to possess a typical ⫺35/⫺10 70 promoter (18, 28, 29, 33).
However, sequence information alone is likely insufficient for
distinguishing between s and 70 promoters, inasmuch as s
and 70 are highly related and recognize the same core promoter elements (19, 24). Recent studies have shown that s
promoter selectivity is attained by several promoter-specific
sequence elements, architectural DNA-binding proteins, or
DNA topology (24). For example, in Escherichia coli, s preferentially recognizes promoters on a relaxed template (26) and
DNA relaxation is required for transcription by the holoenzyme containing s (Es) during the cellular response to osmotic stress (6). Interestingly, in B. burgdorferi, the regulation
of ospC gene expression involves not only the RpoN-RpoS
signaling pathway (25) but also DNA supercoiling (1), raising
the possibility that ospC utilizes a s-dependent promoter.
Additional experiments are therefore warranted to define
whether the ospC gene utilizes a 70 or a s promoter.
Regarding initial efforts to investigate ospC promoter activity, Sohaskey et al. (49) first showed that when transiently
expressed in B. burgdorferi, a 551-bp promoter region of ospC
was capable of driving the expression of a chloramphenicol
acetyltransferase (CAT) reporter gene. Carroll et al. (8) later
constructed a stable shuttle vector for B. burgdorferi in which
the 179-bp region upstream of ospC (containing the IRs) was
fused to a green fluorescent protein (gfp) reporter gene. When
subjected to different environmental conditions, the construct
in B. burgdorferi regulated the expression of GFP akin to OspC
expression (8). More recently, Eggers et al. (13) further analyzed the activity of the ospC promoter in a surrogate E. coli
background using another gfp reporter system. Despite these
efforts, a direct examination of the ospC promoter element and
its influence on OspC expression in the relevant B. burgdorferi
background has been lacking. To this end, we previously constructed an ospC mutant complemented with a shuttle vector
harboring a complete wild-type ospC gene (37). Herein, we
used this construct to generate nested deletions within the
upstream regulatory region of ospC; this approach has allowed
us to identify the cis element involved in ospC regulation in the
native background of B. burgdorferi. The implications of our
findings relative to the control of ospC expression by the
RpoN-RpoS regulatory pathway in B. burgdorferi are discussed.

MATERIALS AND METHODS
Bacterial strains and culture conditions. Low-passage, wild-type clone
BbAH130 of B. burgdorferi strain 297, the OspC-deficient mutant, the OspCdeficient mutant complemented with a shuttle vector carrying a wild-type ospC
gene, and the RpoS-deficient mutant were described previously (25, 37). Highpassage B. burgdorferi strain 297 was obtained by continuously passaging it more
than 230 times in vitro, and a high-passage B. burgdorferi strain B31 (B31-A) was
provided by Patricia Rosa (5). Spirochetes stored at ⫺70°C were inoculated into
Barbour-Stoenner-Kelly-H (BSK-H) medium (Sigma Chemical Co., St. Louis,
MO) (38) and were cultivated under various environmental conditions of temperature (23o or 37°C) and pH (7.5 or 8.0) (58). Cultures were harvested for
analysis at the late logarithmic phase of growth (5 ⫻ 107 cells/ml), as determined
by enumerating spirochetes via dark-field microscopy. For coumermycin A1
experiments, E. coli strain DH5␣ was grown at 23°C and then was diluted 1:100
in Luria-Bertani broth (with or without 1 g/ml of coumermycin A1). Cultures
were allowed to grow at 23°C for about 2 h (optical density at 600 nm of about
0.4). B. burgdorferi was cultivated in BSK-H medium at 23°C until the midlogarithmic phase of growth, at which time the culture was diluted 1:100 in
BSK-H medium containing or lacking 20 ng/ml of coumermycin A1; the cultures
were then allowed to grow at 23°C (for about 2 weeks) to the mid-logarithmic
phase. E. coli TOP10 (Invitrogen, Carlsbad, CA) was used as a host for cloning
experiments.
Promoter mutagenesis. Construction of the shuttle vector pOspC-wt (pBSV2OspC) was described previously (37). pOspC-wt contains the complete coding
region of ospC as well as the 141-bp sequence upstream of the ATG initiation
codon (see Fig. 3A). To construct shuttle vectors with various deletions in the
region of the ospC promoter, a series of PCRs using the Expand High Fidelity
PCR system (Roche Diagnostics, Indianapolis, IN) were performed. The template was pOspC-wt, and the primer pairs for each construct are listed in Table
1. The resulting PCR fragments were cloned into pCR-XL-TOPO (Invitrogen,
Carlsbad, CA). The resulting plasmids and pOspC-wt were then digested with
HindIII and XbaI and ligated together to generate pOspC-⌬IR1, pOspC⌬IR1⫹2, pOspC-min, and pOspC-⌬-35. To construct a pOspC-C/A point mutation, a QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) was
used with the corresponding primer pairs (Table 1). The template used was
pOspC-wt. Sequence analysis was performed to verify the desired mutation. A
resultant HindIII-XbaI fragment was excised and then subcloned back into
pOspC-wt to ensure that only the desired mutation was present in pOspC-C/A.
B. burgdorferi transformations. The OspC-deficient (streptomycin-resistant)
mutant (37) or the RpoS-deficient (erythromycin-resistant) mutant (25) was
made electrocompetent and transformed with various shuttle vector constructs.
Transformants were selected by kanamycin treatment. The general procedure for
transforming B. burgdorferi has been described previously (42, 62). Twenty to 50
g of plasmid DNA was used in each transformation experiment. After electroporation, the mixture (0.05 ml) was diluted into 100 ml of BSK-H medium and
was incubated at 32°C overnight to allow for recovery. Relevant antibiotics were
added to the cultures in the following final concentrations: 50 g/ml for streptomycin, 50 ng/ml for erythromycin, and 200 g/ml for kanamycin. The cultures
were then aliquoted into multiple 96-well tissue culture plates (230 l/well). Two
to 3 weeks after plating, the wells that contained positive cultures were identified
by color change of the medium; the presence of viable spirochetes was verified by
dark-field microscopy. In general, 10% or less of the wells were positive for
growth and therefore were considered to be clonal as a result of limiting dilution
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TABLE 1. Oligonucleotide primers used in this study

Primer name

Sequence

Purpose

ospC-wt-5⬘

CAAATTAAGACAATATTTTTCAAATTC

ospC-IR1

ATAAATATTGAAGAATTTG

ospC-no-IR

AAATATTTTTTCAAATAAA

ospC-min

AATTGAAAAACAAAATTGTTGGACTA

ospC-no-35

GTTGGACTAATAATTCATAAATAA

ospC-wt-3⬘

GATCTAGACAAGAAATCTTTCTTGACTTATATTGA

ospC-C/A-5⬘

GAGATCTAAATATTTTTTCAAATAAAAAATTGAAAAACAAAATTG
TTGGAATAATAATTCATAAATAAAAAG

ospC-C/A-3⬘

CTTTTTATTTATGAATTATTATTCCAACAATTTTGTTTTTCAATTTT
TTATTTGAAAAAATATTTAGATCTC

(10). To confirm that these clones harbored the desired shuttle vector, whole-cell
lysates were used to transform E. coli TOP10. Plasmid DNA was rescued from E.
coli transformants, and restriction digestions were performed to verify recovery
of the pertinent plasmid.
RT-PCR. Total RNAs from B. burgdorferi were isolated using a NucleoSpin
RNA II purification kit (BD Biosciences, Palo Alto, CA) according to instructions provided by the manufacturer. To remove potential DNA contamination,
RNA was further treated with DNA-free DNase Treatment and Removal Reagents (Ambion, Austin, TX). The concentration of RNA was determined by UV
spectrophotometry using an ND-1000 UV-Vis spectrophotometer (NanoDrop
Technologies, Wilmington, DE). RT-PCRs were performed using a Titan One
Tube RT-PCR system (Roche Diagnostics, Indianapolis, IN). Conditions for
reverse transcriptase (RT)-PCRs were as recommended by the manufacturer; a
50-l buffered reaction mixture contained 40 ng of bacterial RNA, 0.4 M
concentrations of each of the oligonucleotide primers, 5 mM dithiothreitol, 0.2
mM concentrations of each deoxynucleoside triphosphate, 5 U of RNase inhibitor, and 1 l of enzyme mixture. Primers used for amplification of ospC and rpoS
transcripts were described previously (25). Five microliters of the RT-PCR mixture was used for agarose gel electrophoresis.
SDS-PAGE and immunoblotting. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblotting were carried out as previously
described (60). Cells were loaded in gel lanes at 5 ⫻ 107 cells per lane. Rat
polyclonal antisera against OspC and s and monoclonal antibody 8H3-33
against FlaB were described previously (58). For coumermycin A1 experiments,
OspC was detected by immunoblotting with monoclonal antibody 4B8F4 (for
detection in E. coli) (33) or with rabbit polyclonal antiserum (for detection in B.
burgdorferi). Most immunoblots were developed colorimetrically; for some of
these, densitometry was used to assess the relative amounts of protein per gel
lane using a Kodak Gel Logic 200 instrument with 1D image analysis software
(version 3.6; Kodak, Rochester, NY). For other selected immunoblots (e.g.,
coumermycin A1 experiments and certain experiments involving the detection of
s), blotted membranes were developed by chemiluminescence using either ECL
Plus Western Blotting Detection system (Amersham Biosciences, Piscataway,
NJ) or Western Lightning Chemiluminescence Reagent Plus (PerkinElmer Life
Sciences, Boston, MA).

RESULTS
trans-Complementation for studying the ospC promoter. As
an initial approach for assessing how ospC is controlled by
RpoS, we exploited a previously constructed ospC mutant of B.
burgdorferi (OspC⫺) complemented with a wild-type version of
ospC that was cloned into the shuttle vector pBSV2 (pOspCwt) (37, 53) (Fig. 2A and B). The advantage of our approach

5⬘ primer; PCR of the ospC gene
for constructing pOspC-wt
5⬘ primer; PCR of the ospC gene
for constructing pOspC-⌬IR1
5⬘ primer; PCR of the ospC gene
for constructing pOspC-⌬IR1 ⫹ 2
5⬘ primer; PCR of the ospC gene
for constructing pOspC-min
5⬘ primer; PCR of the ospC gene
for constructing pOspC-⌬-35
3⬘ primer; PCR of the ospC gene
for constructing all of the
plasmids listed above. An XbaI
site (boldface letters) is attached
for the purpose of cloning.
5⬘ primer; generation of a C/A
mutation at the ⫺15 position
within the ospC promoter
3⬘ primer; generation of a C/A
mutation at the ⫺15 position
within the ospC promoter

was that ospC expression could be assessed directly via the
detection of OspC in B. burgdorferi. To first examine whether
regulation of the cloned ospC gene in pOspC-wt was similar to
that of a native, endogenous ospC gene, wild-type B. burgdorferi and the complemented OspC mutant (OspC⫺/pOspC-wt)
were cultivated in BSK-H medium under various temperature
and pH conditions. In both wild-type B. burgdorferi and the
OspC⫺/pOspC-wt complemented strain, ospC expression was
induced at an elevated temperature (Fig. 2C, lanes 2 and 8)
and was inhibited by increased culture pH (Fig. 2C, lanes 3 and
9). These results confirmed that the ospC gene located on a
shuttle vector responded to environmental stimuli in a manner
similar to that of an endogenous ospC gene, indicating the
suitability of trans-complementation for assessing ospC gene
regulation.
IR elements are not required for the expression of ospC.
Previously, two partially overlapping IRs were identified upstream of the ospC gene of B. burgdorferi (29) (Fig. 1). These
IRs are highly conserved among ospC homologs of many B.
burgdorferi strains (29, 55) and have been hypothesized to be
involved in ospC regulation (1, 55). To assess the potential
role(s) of the IRs in ospC expression, we first generated
complementation constructs lacking either IR1 or both IR1 and
IR2 (Fig. 3A). The resulting mutated constructs were then
transformed into the OspC⫺ mutant, and OspC expression was
monitored by immunoblot analysis. Densitometry revealed
that plasmids harboring either deletion construct in the OspC⫺
mutant still promoted the expression of OspC (lanes 4 and 5)
at levels close to that for the wild type (lane 3), indicating that
neither of the two IRs upstream of ospC is required for ospC
expression.
Minimum promoter for ospC expression. Deletion of the
two IRs removed the majority of the sequence upstream of the
⫺35/⫺10 promoter of ospC that was previously noted by others
(18, 28, 29, 33) (Fig. 3A). To further examine whether an
additional 18 bp remaining immediately upstream of the ⫺35
consensus sequence played a role in ospC regulation, the 18-bp
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FIG. 2. Approach for studying the regulation of ospC. (A) Structure of the ospC locus in cp26 (top) and ospC disruption by the aadA
(streptomycin resistance) marker (16) (bottom). Only the relevant
portions of cp26 are shown. WT, wild type. (B) The shuttle vector
pBSV2 (53) harboring a wild-type copy of ospC (pOspC-wt) used for
genetic complementation of the ospC mutant of B. burgdorferi. In this
construct, the kanamycin resistance gene is driven by the constitutive
promoter of the borrelial flgB gene (PflgB-Kan). (C) SDS-PAGE (Coomassie blue staining) (top) and immunoblotting (bottom) of whole-cell
lysates of B. burgdorferi strains cultivated under various conditions of
temperature and pH. M, molecular mass marker (in kilodaltons). WT,
parental low-passage B. burgdorferi 297. OspC⫺, the ospC mutant.
OspC⫺/pOspC-wt, the ospC mutant complemented with the shuttle
vector pOspC-wt. Lanes 1, 4, and 7, spirochetes cultivated in BSK-H
medium (pH 7.5) incubated at 23°C. Lanes 2, 5, and 8, spirochetes
cultivated in BSK-H medium (pH 7.5) at 37°C. Lanes 3, 6 and 9,
spirochetes cultivated in BSK-H medium (37°C) adjusted to pH 8.0.
The migration of OspC in the Coomassie blue-stained gel (top) is
indicated by the arrow. In the immunoblot (bottom), only the relevant
portion of the gel is shown.

region was deleted. The resulting construct contained only the
minimal ⫺35/⫺10 sequence (pOspC-min) (Fig. 3A). The
OspC⫺ mutant of B. burgdorferi complemented with pOspCmin readily expressed OspC (Fig. 3B, lane 6). However, a
complementation construct lacking an additional 17 nucleotides extending into the putative ⫺35 consensus sequence had
greatly diminished OspC expression in the OspC⫺ mutant (Fig.
3B, lane 7). These results indicate that a minimal ⫺35/⫺10
ospC promoter sequence is necessary and sufficient for OspC
expression in B. burgdorferi.
Recent data demonstrate that although the ⫺35/⫺10 con-
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FIG. 3. Influence of upstream cis elements on ospC expression.
(A) Diagram of a series of shuttle vector constructs containing various
versions of the upstream region of ospC. Nucleotide positions are
relative to the ATG start codon, where A is position ⫹1. All six
constructs are denoted by the prefix pOspC- followed by the pertinent
deletion or mutation (indicated at the left). wt, wild-type aspC gene;
⌬IR1, deletion of IR1; ⌬IR1⫹2, deletion of IR1 and IR2; min, minimal
promoter for ospC; ⌬-35, deletion of IR1, IR2, and the ⫺35 sequence;
C/A, targeted point mutation of C (within the extended ⫺10 region) to
A. (B) Immunoblot of the ospC mutant (OspC⫺) transformed with the
various pOspC shuttle vectors shown in panel A. All cultures were
grown at 37°C (pH 7.5) and were harvested at the late logarithmic
phase of growth. Antibodies directed against OspC and FlaB were
pooled. Numbers at the left denote protein molecular mass markers
(in kilodaltons). Densitometry results for OspC are as follows: lane 1,
2.0; lane 2, 0.008; lane 3, 2.3; lane 4, 2.2; lane 5, 2.0; lane 6, 1.7; lane
7, 0.05; and lane 8, 0.2. WT, wild type.

sensus sequences for s and 70 promoters tend to be indistinguishable (19, 24), some minor sequence differences may
exist, especially within the extended ⫺10 element (4). In this
regard, a ⫺13 C residue in this extended ⫺10 region is strategic for interacting with Es in E. coli (4). We therefore mutagenized a candidate C residue conserved at position ⫺15
within the ospC minimal promoter (Fig. 1) and assessed the
influence of this point mutation on ospC expression. As shown
in Fig. 3B (lane 8), the OspC⫺ mutant complemented with this
construct expressed significantly lower levels of OspC than the
mutant transformed with the wild-type ospC gene.
To examine whether the ospC gene driven only by a minimal
promoter remained responsive to environmental stimuli, B.
burgdorferi strain OspC⫺/pOspC-min was cultivated under various conditions of temperature and pH. As in the case of either
wild-type B. burgdorferi or OspC⫺/pOspC-wt (Fig. 2C), ospC
expression in the OspC⫺/pOspC-min strain was inhibited by
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FIG. 4. Influence of culture temperature and pH on ospC expression driven by a minimal promoter. Spirochetes were cultivated in
BSK-H medium (pH 7.5) at 23°C (lanes 1) or 37°C (lanes 2) or
adjusted to pH 8.0 in medium at 37°C (lanes 3). Whole-cell lysates
were either stained with Coomassie blue (left) or immunoblotted with
pooled antibodies directed against FlaB and OspC (right). Numbers at
the left denote protein molecular mass markers (in kilodaltons).

decreased temperature and increased culture pH (Fig. 4, lanes
1 and 3), indicating normal ospC regulation.
s controls ospC expression via the minimal promoter.
Wild-type ospC expression is controlled via the RpoN-RpoS
regulatory network, which culminates in s regulating ospC
expression (25, 61). To garner evidence that s directly controls ospC expression via interaction with the minimal promoter, the complementation construct pOspC-min was transformed into an rpoS-deficient mutant of B. burgdorferi (25).
The resulting strain, RpoS⫺/pOspC-min, no longer expressed
ospC at either the RNA or protein level (Fig. 5), demonstrating

FIG. 5. ospC expression driven by the minimal promoter is s dependent. Top panel, immunoblot of whole-cell lysates of the ospC mutant
(OspC⫺), ospC mutant transformed with pOspC-min (OspC⫺/pOspCmin), or an rpoS mutant (RpoS⫺) transformed with pOspC-min. All
cultures were grown at 37°C and harvested at the late logarithmic phase
of growth. Antisera directed against s and OspC were pooled for immunoblotting. Numbers at the left denote protein molecular mass markers
(in kilodaltons). Bottom two panels, RT-PCR and agarose gel electrophoresis for the detection of ospC and rpoS transcripts, respectively. Only
the relevant portions of the agarose gel are shown.

J. BACTERIOL.

FIG. 6. Influence of coumermycin A1 on ospC expression driven by
various promoter constructs. (A) E. coli strain DH5␣ carrying various
mutant ospC promoters (top of panel A; abbreviations as defined for Fig.
3A) was treated (⫹) or not treated (⫺) at 23°C with 1 g/ml of coumermycin A1. (B) Wild-type (WT) B. burgdorferi or various complemented
derivatives of the ospC mutant (OspC⫺) (top of panel B; abbreviations as
in Fig. 3A) were either treated (⫹) or not treated (⫺) at 23°C with 20
ng/ml of coumermycin A1. Whole-cell lysates were then immunoblotted
with either monoclonal antibody (panel A) or antiserum (panel B) directed against OspC and developed using chemiluminescence.

that s controls ospC expression via the minimal promoter.
Influence of coumermycin A1 on activity of the ospC promoter. Elevated culture temperature reduces DNA supercoiling in B. burgdorferi that, in turn, induces the expression of
ospC (1). This same OspC induction was mimicked by treatment of B. burgdorferi with coumermycin A1, an inhibitor of
DNA gyrase that also culminates in decreased DNA supercoiling (43). Relaxation of supercoiling is one of the factors that
enhances promoter selectivity by Es (24). In addition, the IRs
were postulated to play a role in the regulation of ospC by
supercoiling (1). To examine which ospC promoter element(s)
responds to DNA supercoiling, E. coli (Fig. 6A) and the B.
burgdorferi OspC⫺ mutant (Fig. 6B) carrying the complementing plasmids were cultivated at room temperature and treated
with coumermycin A1. In the heterologous E. coli strain transformed with a wild-type ospC gene, OspC is not expressed by
E. coli cultivated at room temperature, whereas coumermycin
A1 treatment induced the expression of OspC in E. coli cultivated under the same conditions (Fig. 6A). This same coumermycin A1 induction effect was obtained in E. coli when IR1 of
ospC was absent (Fig. 6A). However, plasmid constructs that
lacked both IR1 and IR2 (pOspC-⌬IR1⫹2) or that contained
only the minimal promoter (pOspC-min) failed to respond to
coumermycin A1 treatment (Fig. 6A). In wild-type B. burgdorferi cultivated at room temperature for 2 weeks, 20 ng/ml of
coumermycin A1 also induced the expression of ospC (Fig. 6B).
The same coumermycin A1 induction effect was observed with the
OspC⫺ strain of B. burgdorferi complemented with either a wildtype copy of ospC (pOspC-wt) or the minimal promoter of ospC
(pOspC-min) (Fig. 6B). Treatment of the same complemented
strains of B. burgdorferi with 100 ng/ml of coumermycin A1 for
24 h yielded the same results (data not shown). Of note, the
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FIG. 7. s expression correlates with OspC expression in low- and
high-passage strains of B. burgdorferi 297 and B31. Low-passage (LP)
and high-passage (HP) B. burgdorferi strains 297 and B31 were cultivated in BSK-H medium at 37°C and were harvested at the late logarithmic stage of growth. Antisera directed against s and OspC were
pooled for immunoblotting. Numbers at the left denote protein molecular mass markers (in kilodaltons).

minimal promoter of ospC remained responsive to coumermycin
A1 treatment and, thus, to a DNA supercoiling effect in B. burgdorferi, but not in E. coli transformed with the same plasmid.
Loss of ospC expression correlates with the loss of s in
high-passage populations of B. burgdorferi. Continuous serial
passage of B. burgdorferi in vitro results in a reduction or loss
of OspC expression (30, 47, 57). Inasmuch as our data indicate
that the expression of ospC is under the direct control of s, we
investigated whether the loss of OspC expression in high-passage
populations of B. burgdorferi correlated with a concomitant loss of
s. To examine this, low- and high-passage populations of B.
burgdorferi strains 297 and B31 were subjected to SDS-PAGE and
immunoblotting for colorimetric detection of OspC and s (Fig.
7). OspC was absent in high-passage strain B31, a finding that
correlated with an undetectable level of s (Fig. 7). A minimal
quantity of OspC was detected in high-passage strain 297 even
though s also was not detectable in the same strain (Fig. 7).
However, when similar immunoblots were developed by a more
sensitive chemiluminescence method, a small amount of s was
detected (data not shown). These combined findings suggest that
the continuous in vitro passage of B. burgdorferi results in a loss of
s that, in turn, leads to the loss of ospC expression.
DISCUSSION
The B. burgdorferi genome encodes about 175 known or
putative lipoprotein genes comprising about 10% of the total
B. burgdorferi genomic coding capacity (9, 17). This remarkable
feature distinguishes B. burgdorferi from virtually all other
pathogenic bacteria (17) and has engendered the contention
that the membrane lipoproteins likely play an important role in
the adaptation of B. burgdorferi to both its arthropod and
mammalian hosts (22, 54). In this regard, it is increasingly well
documented that a number of these lipoproteins indeed are
differentially expressed during the transmission of B. burgdorferi between ticks and mammals (2); recent demonstration of
the essential roles for the OspA and OspC in spirochete transmission and mammalian infection further underscores the importance of lipoproteins in the complex life cycle of B. burgdorferi (21, 37, 62). Continuing efforts to elucidate the
molecular mechanisms that modulate the expression of borre-
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lial lipoproteins thus likely will hold the key for understanding
how B. burgdorferi survives in nature via its complex adaptive
responses (22, 41, 46).
Previously, we identified a novel genetic regulatory network,
the RpoN-RpoS pathway, that governs the expression of several borrelial lipoproteins, including OspC, DbpA, and the
Mlp family (i.e., “group I” lipoproteins) (58). In the present
study, we exploited ospC as a model system for further understanding the mechanism(s) governing the expression of lipoprotein genes regulated by the RpoN-RpoS pathway. Regulation by the RpoN-RpoS pathway, however, is predicated on
the requirement for a s-dependent promoter to drive expression of the downstream target gene. Prior reports, however,
have suggested that the ospC promoter was the 70 type (based
on sequence analysis and primer extension studies) (18, 28, 29,
33), and the additional presence of two conserved IR elements
upstream of the ospC gene potentially also constituted a binding site(s) for a putative transactivator of ospC regulation. As
such, one attractive hypothesis has been that ospC actually is
regulated indirectly by the RpoN-RpoS pathway via the induction of a requisite transactivator, followed by expression of
ospC via a 70-like promoter.
By exploiting an ospC mutant of B. burgdorferi and a shuttle
vector carrying a wild-type copy of ospC, herein we now have
provided several lines of evidence that the ospC gene likely is
regulated directly by the binding of s to its s-dependent
promoter. First, the two IRs (potential transactivator-binding
site[s]) were dispensable; a minimal ⫺35/⫺10 promoter sequence was both necessary and sufficient for ospC expression.
Second, the minimal ospC promoter defined in our study remained responsive to key environmental stimuli typically associated with the regulation of ospC (e.g., temperature and pH).
Third, as shown in complementation studies with a s-deficient
mutant of B. burgdorferi, the ospC gene containing the minimal
promoter remained s dependent. Fourth, consistent with the
fact that Es polymerase binds preferentially to relaxed DNA
(26), ospC expression controlled by the minimal promoter increased in response to coumermycin A1.
The alternative sigma factor s is a general stress factor that
controls the expression of many genes essential for bacterial
stationary-phase adaptation (23). Although s modulates the
expression of a distinct group of genes, its structure and molecular function are very similar to those of the housekeeping
sigma factor, 70 (RpoD), and the consensus promoter sequence for Es is similar to that used by E70 (19, 24). In fact,
a typical s-dependent promoter binds to both Es and E70 in
vitro, thereby precluding the use of electrophoretic gel shift
assays for distinguishing between s and 70 promoters. As
such, there has been a great interest in elucidating the mechanism by which Es recognizes and discriminates its cognate
promoter in vivo. In E. coli, several factors, such as a high-salt
condition, presence of an additional trans regulator, or the
local relaxation of target DNA, have been shown to contribute
to promoter selectivity for Es (24). In addition, certain promoter sequence elements, especially a C nucleotide within the
extended ⫺10 region, can play an important role in Es selectivity (4). This C nucleotide was suggested to interact with a
key Lys173 residue of s in E. coli (4). In the present study, we
showed that mutation of a candidate ⫺15 C nucleotide within
the extended ⫺10 region of the minimal promoter for ospC
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greatly diminished OspC expression, further suggesting that a
C residue within this extended ⫺10 region also is important for
s-dependent activation in B. burgdorferi. On the other hand,
s of B. burgdorferi does not possess an obvious Lys residue
that corresponds to Lys173 of E coli s. Further experiments
are therefore warranted to identify the residue(s) in B. burgdorferi s involved in interacting with the ⫺15 C nucleotide.
Eggers et al. (13) recently performed an analysis of promoter elements involved in the expression of ospC and other B.
burgdorferi genes using a GFP reporter system in E. coli. Although our results regarding ospC expression are largely in
agreement with those of Eggers et al. (13), some differences
are noteworthy. Eggers et al. (13) showed that deletion of the
IR elements upstream of the ospC promoter significantly reduced the level of ospC promoter activity in B. burgdorferi; it
therefore was concluded that the upstream (IR) region likely
functions as an enhancer-binding site for maximal expression
of ospC. In contrast, densitometry performed on immunoblots
indicated that deletion of both IRs did not dramatically affect
ospC expression in B. burgdorferi. The reason for this discrepancy is unclear but may be grounded in the fact that we assayed
for native OspC expression, whereas Eggers et al. (13) used a
GFP-based reporter assay.
Much of the work reported by Eggers et al. (13) exploited E.
coli as a surrogate system for assessing ospC promoter activity.
Whereas using surrogate systems can be valuable, in our studies we noted differences in the regulation of ospC when present
in E. coli or its native B. burgdorferi background. For example,
IR2 was required for ospC induction by coumermycin A1-induced relaxation of DNA supercoiling in E. coli, but not in B.
burgdorferi. This may be due to differences in s function,
plasmid topology, or other trans-acting factors that exist between the two species. Thus, with continuing advances in borrelial genetics, particularly the applications of targeted mutagenesis, gene inactivation, and improved shuttle vectors,
studying B. burgdorferi gene regulation in the relevant native
background should be the preferred experimental approach.
A distinguishing feature of B. burgdorferi as a prokaryote is
its remarkable plasmid complexity (52). While the extremely
large complement of circular and linear plasmids in B. burgdorferi likely offers a genetic plasticity that allows it to adapt
readily to its diverse arthropod and mammalian hosts, it also
may engender the genetic instability that typifies the population biology of B. burgdorferi (3, 52). The spontaneous loss by
B. burgdorferi in culture of lp25, encoding the pncA gene essential for B. burgdorferi infectivity (39), is a prime example of
this kind of genetic instability (27, 40, 57). Another genetic
phenomenon, yet to be elucidated, is that continuous passage
of B. burgdorferi in vitro also results in greatly diminished ospC
expression (47, 57). Our data appear to provide the first insights into the loss of ospC expression. Namely, the loss of ospC
expression correlated with the apparent loss of (or reduction
in) S within the B. burgdorferi population; such loss in OspC
expression was not attributed to the loss of cp26 or the loss of
ospC or rpoS (data not shown). Although the precise mechanism accounting for this phenomenon thus remains unclear, we
hypothesize that continuous in vitro passage of B. burgdorferi
may adversely influence the ability of Rrp2 to become activated by its cognate histidine kinase, thereby blocking rpoS
expression. Alternatively, S in B. burgdorferi under continuous
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in vitro passage may be susceptible to a form of posttranscriptional regulation, such as proteolysis, that has been observed
for other bacteria (23).
OspC has been classified with other borrelial lipoproteins,
denoted “group I” lipoproteins, such as DbpA, OspF, and the
Mlp family, which appear to be regulated by similar environmental cues. Therefore, the fact that ospC is regulated directly
by s may be applicable to the regulation of other group I
lipoprotein genes. On the other hand, such extrapolation to
other group I lipoprotein genes will require further experimental corroboration, as presented herein for ospC. This is particularly important given the fact that although dbpA is induced
by elevated temperature, its responsiveness to culture pH differs from that of ospC (58). In the case of the mlp genes, they
are coordinately regulated in a pattern very similar, but not
identical, to that of ospC (59). Thus, it is premature to conclude that dbpA or the mlp lipoprotein genes have Es promoters. It is therefore not inconceivable that another layer of
gene regulation, yet to be elucidated, remains for the regulation of other group I lipoprotein genes.
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